RxDoctor Payments Data

Justin Rondinelli, MD

Internal Medicine · Cleveland, OHNPI 1710410477

Payments from drug & device makers

$995in general payments, 2019–2025

Across 55 payments — averaging $18.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$236
  • AstraZeneca$123
  • Exact Sciences$77
  • GSK$75
  • Amgen$58
  • Novartis$55
  • plus $372 from 12 others

What the payments were for

  • Food & beverage$995100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$995 in reported general payments places this provider in the 70th percentile of 4,428 internal medicine providers in Ohio.

See all internal medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$64,362
Medicare patients
215
Services billed
823

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide84$92,486
JardianceEmpagliflozin50$64,536
EliquisApixaban48$58,094
MounjaroTirzepatide37$51,447
TrulicityDulaglutide42$50,955
Trelegy ElliptaFluticasone/Umeclidin/Vilanter29$29,228
FarxigaDapagliflozin Propanediol18$24,413
JanuviaSitagliptin Phosphate12$20,292
XareltoRivaroxaban25$19,563
Gvoke Hypopen 2-PackGlucagon12$7,839
VascepaIcosapent Ethyl12$4,285
Fluticasone-SalmeterolFluticasone Propion/Salmeterol20$3,972
Atorvastatin Calcium428$3,792
Rosuvastatin Calcium199$3,043
Lantus SolostarInsulin Glargine,hum.Rec.Anlog33$2,915

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$15$102,40279 claims
Novo NordiskOzempic$50$92,48684 claims
PfizerEliquis, Paxlovid$23$59,52366 claims
GSKTrelegy Ellipta$75$29,22829 claims
AstraZenecaFarxiga$123$24,41318 claims
MerckJanuvia$52$20,29212 claims
Johnson & JohnsonXarelto$16$19,56325 claims
AbbVieSynthroid$236$1,96138 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 4,428 internal medicine providers in Ohio.

Other internal medicine in Cleveland

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →